Assay ID | Title | Year | Journal | Article |
AID306996 | Cytotoxicity against human MCF7 cells by sulforhodamine B assay | 2007 | Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
| Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. |
AID337172 | Cytotoxicity against human H9 cells | | | |
AID307002 | Cytotoxicity against human MRC5 cells by sulforhodamine B assay | 2007 | Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
| Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. |
AID120695 | Compound was evaluated for the antitumor activity against P388 lymphocytic leukemia in mice | 1985 | Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
| Synthesis and biological effects of novel thiocolchicines. 3. Evaluation of N-acyldeacetylthiocolchicines, N-(alkoxycarbonyl) deacetylthiocolchicines, and O-ethyldemethylthiocolchicines. New synthesis of thiodemecolcine and antileukemic effects of 2-demet |
AID306994 | Cytotoxicity against human 1A9 cells by sulforhodamine B assay | 2007 | Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
| Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. |
AID214887 | Inhibition of tubulin polymerization interacting at the colchicine binding site. | 2000 | Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
| Antitumor agents. 199. Three-dimensional quantitative structure-activity relationship study of the colchicine binding site ligands using comparative molecular field analysis. |
AID253355 | In vitro cytotoxic activity against human lung carcinoma (A549) tumor cell line | 2005 | Bioorganic & medicinal chemistry letters, Jan-03, Volume: 15, Issue:1
| Antitumor agents. Part 236: Synthesis of water-soluble colchicine derivatives. |
AID253356 | In vitro cytotoxic activity against human ovarian carcinoma (1A9) tumor cell line | 2005 | Bioorganic & medicinal chemistry letters, Jan-03, Volume: 15, Issue:1
| Antitumor agents. Part 236: Synthesis of water-soluble colchicine derivatives. |
AID306995 | Cytotoxicity against human A549 cells by sulforhodamine B assay | 2007 | Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
| Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. |
AID214893 | Binding affinity towards tubulin protein measured by their ability to displace [3H]colchicine from rat brain at the dose 25 uM | 1985 | Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
| Synthesis and biological effects of novel thiocolchicines. 3. Evaluation of N-acyldeacetylthiocolchicines, N-(alkoxycarbonyl) deacetylthiocolchicines, and O-ethyldemethylthiocolchicines. New synthesis of thiodemecolcine and antileukemic effects of 2-demet |
AID214548 | In vitro inhibition of mammalian tubulin polymerization by 50% | 1998 | Journal of medicinal chemistry, May-21, Volume: 41, Issue:11
| Antitumor agents. 185. Synthesis and biological evaluation of tridemethylthiocolchicine analogues as novel topoisomerase II inhibitors. |
AID306997 | Cytotoxicity against human LNCAP cells by sulforhodamine B assay | 2007 | Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
| Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. |
AID252064 | Percentage inhibition of multi drug resistant KB subclone growth expressing P-glycoprotein (KB-V) at 4 ug/mL concentration was determined | 2005 | Bioorganic & medicinal chemistry letters, Jan-03, Volume: 15, Issue:1
| Antitumor agents. Part 236: Synthesis of water-soluble colchicine derivatives. |
AID211307 | In vitro activity against mammalian topoisomerase II measured as ATP-dependent unknotting of P4 DNA compared to enzyme and DNA control; Inactive | 1998 | Journal of medicinal chemistry, May-21, Volume: 41, Issue:11
| Antitumor agents. 185. Synthesis and biological evaluation of tridemethylthiocolchicine analogues as novel topoisomerase II inhibitors. |
AID306999 | Cytotoxicity against human DU145 cells by sulforhodamine B assay | 2007 | Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
| Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. |
AID117073 | Lethal dose after the intraperitoneal injection in a group of 10 mice | 1985 | Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
| Synthesis and biological effects of novel thiocolchicines. 3. Evaluation of N-acyldeacetylthiocolchicines, N-(alkoxycarbonyl) deacetylthiocolchicines, and O-ethyldemethylthiocolchicines. New synthesis of thiodemecolcine and antileukemic effects of 2-demet |
AID253360 | In vitro cytotoxic activity against human epidermoid carcinoma of the nasopharynx (KB) tumor cell line | 2005 | Bioorganic & medicinal chemistry letters, Jan-03, Volume: 15, Issue:1
| Antitumor agents. Part 236: Synthesis of water-soluble colchicine derivatives. |
AID115600 | MED(minimum effective dose) against P388 lymphocytic leukemia in mice; this dose produced T/C greater than the threshold value of 125 | 1985 | Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
| Synthesis and biological effects of novel thiocolchicines. 3. Evaluation of N-acyldeacetylthiocolchicines, N-(alkoxycarbonyl) deacetylthiocolchicines, and O-ethyldemethylthiocolchicines. New synthesis of thiodemecolcine and antileukemic effects of 2-demet |
AID306998 | Cytotoxicity against human PC3 cells by sulforhodamine B assay | 2007 | Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
| Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. |
AID337171 | Antiviral activity against HIV1 HTLV-3B in human H9 cells after 3 days by p24 antigen capture assay | | | |
AID109716 | Antitumor activity against P388 lymphocytic leukemia in mice | 1985 | Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
| Synthesis and biological effects of novel thiocolchicines. 3. Evaluation of N-acyldeacetylthiocolchicines, N-(alkoxycarbonyl) deacetylthiocolchicines, and O-ethyldemethylthiocolchicines. New synthesis of thiodemecolcine and antileukemic effects of 2-demet |
AID307001 | Cytotoxicity against multi drug-resistant human KBVIN cells by sulforhodamine B assay | 2007 | Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
| Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. |
AID213858 | Percentage by which the binding of [3H]colchicine (2.5 uM) to tubulin from calf brain is reduced by 25 uM concentration of compound | 1987 | Journal of medicinal chemistry, Apr, Volume: 30, Issue:4
| A novel synthesis of colchicide and analogues from thiocolchicine and congeners: reevaluation of colchicide as a potential antitumor agent. |
AID307000 | Cytotoxicity against human KB cells by sulforhodamine B assay | 2007 | Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
| Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents. |
AID241148 | Inhibitory concentration against tubulin assembly | 2005 | Bioorganic & medicinal chemistry letters, Jan-03, Volume: 15, Issue:1
| Antitumor agents. Part 236: Synthesis of water-soluble colchicine derivatives. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |